The µ-opioid receptor (µOR) is a G-protein-coupled receptor (GPCR) and the target of most clinically and recreationally used opioids. The induced positive effects of analgesia and euphoria are mediated by µOR signalling through the adenylyl cyclase-inhibiting heterotrimeric G protein G i . Here we present the 3.5 Å resolution cryo-electron microscopy structure of the µOR bound to the agonist peptide DAMGO and nucleotide-free G i . DAMGO occupies the morphinan ligand pocket, with its N terminus interacting with conserved receptor residues and its C terminus engaging regions important for opioid-ligand selectivity. Comparison of the µOR-G i complex to previously determined structures of other GPCRs bound to the stimulatory G protein G s reveals differences in the position of transmembrane receptor helix 6 and in the interactions between the G protein α-subunit and the receptor core. Together, these results shed light on the structural features that contribute to the G i protein-coupling specificity of the µOR.
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suggesting that the µOR recognizes structurally distinct agonists in a stereotypic manner.
Although DAMGO is a flexible ligand, we observe density for the entire peptide bound to the receptor (Fig. 1a , Extended Data Figs. 3, 4) . The N terminus of DAMGO occupies a similar position in the binding pocket as BU72. By contrast, the C terminus of DAMGO extends ~8 Å further towards the extracellular loops compared to BU72 (Fig. 1d, e ). To identify stable atomic-level interactions between DAMGO and the binding pocket, we performed molecular dynamics simulations. In over 1 µs of simulation, DAMGO remained close to its initially modelled pose, with the N-terminal portion largely remaining confined to the experimentally determined cryo-EM density (Fig. 1f , Extended Data Fig 5) . The N terminus of DAMGO maintained a persistent salt bridge with D147 3.32 , a feature previously observed in structures of morphinans bound to opioid receptors ( Fig. 1e ; superscripts indicate Ballesteros-Weinstein numbering for GPCRs 13 ). The same amine group also frequently formed a hydrogen bond with Y326 7.43 . More generally, the N-terminal Tyr of DAMGO overlaps the phenolic groups of other small-molecule opioids that have been characterized in complex with µOR or other opioid receptors by X-ray crystallography [14] [15] [16] [17] .
Molecular dynamics simulations also revealed a water-mediated hydrogen bonding network that closely overlaps with the water network observed in the high-resolution crystal structure of µOR 12 (Extended Data Fig. 6 ). In particular, the simulations revealed a stable, watermediated interaction that is formed between the phenol of DAMGO and H297 6.52 . Although the crystal structure of the µOR bound to BU72 shows two water molecules bridging the DAMGO phenol and H297 6.52 , simulations of µOR bound to DAMGO and other phenolic ligands 8, 12 suggest that one of these water molecules rapidly dissociates, and that a single water is required for stable ligand binding. This interaction is a hallmark of opioid recognition that has been observed for morphinans in complex with the µOR 12, 14 as well as other small molecule and peptide-mimetic agonists of the homologous δand κ-opioid receptors (δOR and κOR) 15, 16, 18 .
DAMGO exhibits more than 500-fold selectivity for the µOR over the δOR and κOR 19 . Structural studies have shown that interactions of ligands with the extracellular loops encode ligand subtype specificity among closely related opioid receptors 15 . Indeed, DAMGO selectivity for µOR over δOR has been shown to depend on residues in extracellular loop (ECL) 1, whereas selectivity over κOR results from differences in ECL3 20 . The map density for the C-terminal residues of DAMGO is slightly weaker than for the amino terminus, consistent with increased mobility of this region in simulations ( Fig. 1f , Extended Data Fig 5) . In our model, the N(Me)Phe side chain of DAMGO occupies a conserved hydrophobic pocket near ECL1 and the Gly-OH group folds back over the ligand (Fig. 1e ). This model is consistent with the high affinity of µOR binding to cyclized enkephalins, which bridge the +2 and +5 positions of the peptide 21 .
Structure of G i -stabilized active µOR
The overall structure of G i -bound µOR is similar to the active conformation of the BU72-bound µOR stabilized by Nb39 12 (root mean square deviation of 1 Å) with a predominant outward displacement of transmembrane helix (TM) 6 from the heptahelical bundle relative to the inactive state ( Fig. 2a, b) . A number of highly conserved residues in the GPCR family have been shown to be important for receptor activation, including the D 3.49 R 3.50 Y 3.51 , N 7.49 P 7.50 XXY 7. 53 and conserved core triad (I 3.40 , P 5.50 , F 6.44 ) motifs. The conformation of each of these regions in the µOR-G i complex is virtually identical to the active state observed in the complex with Nb39 (Fig. 2c ). The structural similarity of µOR between Nb39 and G i -bound states indicate that these changes underlie ligand-mediated activation and are not specific to a particular intracellular binder. Indeed, Nb39 and G i promote a similar increase in agonist affinity 12 , supporting a common mechanism of allosteric communication between the intracellular G-protein-coupling domain and the ligand-binding pocket 12 . cyan, Gβ; purple, Gγ. b, Model of the µOR-G i complex in the same views and colour scheme as shown in a. c, Residues that line the µOR orthosteric binding pocket are shown as sticks for the µOR-G i complex (green) and the µOR-Nb39 complex (PDB code 5C1M; blue). The binding pocket residues of µOR in complex with DAMGO and BU72 show nearly identical conformations, despite differences in ligand structure. d, Comparison of BU72 (yellow carbons) in the orthosteric pocket of the µOR-Nb39 complex (blue) with DAMGO (orange carbons) in the orthosteric pocket of the µOR-G i complex (green). e, view of DAMGO in the orthosteric binding pocket with critical residues shown. f, A frame from every 100 ns of a 1 µs molecular dynamics simulation (yellow at t = 0, fading to red at t = 1 µs) shows that the first four residues of DAMGO (bottom) are stable, whereas the C-terminal Gly-ol (top) is dynamic but frequently returns to the modelled pose. a   b   TM2   TM3   TM5   TM6   TM7   TM1   D147 3.32   TM6   TM7   TM2   TM3   90º   e   TM5   TM6   TM7   TM2   TM3   TM3   TM7   Early simulation   Late simulation   DAMGO poses   TM6   TM5   W133 V143 3.28
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Two differences between Nb39-and G i -stabilized active states of µOR are particularly notable. First, compared with the nanobody-stabilized active-state µOR, TM6 in the µOR-G i complex is further displaced by 3 Å towards TM7 ( Fig. 2b) . Second, the conformation of intracellular loop (ICL) 3 is different between the two structures ( Fig. 2b) . It is likely that the specific ICL3 conformation of Nb39-stabilized µOR reflects interactions that are unique to the nanobody rather than a general feature of receptor activation prior to G-protein coupling. A similar difference in ICL3 conformation was previously observed for the β 2 -adrenergic receptor (β 2 AR) between nanobody 22 (Nb80) and G scoupled states. The comparison of the G-protein-bound states of both receptors shows that TM6 of β 2 AR is displaced outward by a further 9 Å in comparison to that of the µOR (Fig. 2d ).
Structural changes in G i
The quality of the cryo-EM map enabled accurate modelling of G i in its nucleotide-free state, providing insight into the structural changes that underlie nucleotide release. The changes are similar to those seen in nucleotide-free G s in complex with other GPCRs. The most striking difference between the GDP-bound 23 and nucleotide-free heterotrimer in complex with µOR involves the separation of the α-helical domain (AHD) from the Ras-like domain in Gα i (Fig. 3a ). Owing to its relative flexibility, we excluded the AHD density from the high-resolution map refinement. The dynamic character of the AHD has been observed previously in spectroscopic and structural studies of complexes between receptors and G s 9-11 and G i 24, 25 . Displacement of the AHD disrupts several contacts with GDP and is necessary, but not sufficient, for nucleotide release, a process that involves breaking additional contacts with the Ras domain 24 .
Coupling of G i to the µOR also involves a 6 Å translation as well as a 60° rotation of the α5-helix of Gα i into the receptor core ( Fig. 3b ). This movement has been shown to be essential for nucleotide release by G i 24 .
In particular, the movement of α5 leads to a change in the position of the β6-α5 loop containing the conserved TCAT motif that forms direct interactions with the guanine base of GDP. This displacement disrupts key contacts between the G protein and nucleotide. Furthermore, the observed translation and rotation of the α5-helix requires the displacement of the fully conserved F336 away from the hydrophobic pocket formed by residues in the β2 and β3 strands and the α1 helix 26 (Fig. 3b ). Movement of the α5-helix is also propagated to the phosphate-binding P loop connecting the β1 strand and the α1 helix by disruption of a hydrophobic network between the α1 and α5 helices ( Fig. 3b-d ). Correspondingly, upon transition of G i to the nucleotide-free state, we observe a 4 Å shift of α1 towards the α5-helix in G i whereby the hydrophobic contacts are replaced by polar interactions with the β6-α5 loop as it is released from its guanine-binding position ( Fig. 3c, d ). These changes are in contrast to those observed in structures of G s -coupled complexes, in which α1 not only becomes more unstructured, but also tends to lose interactions with the α5-helix ( Fig. 3e ). Our structure is consistent with previous studies suggesting that engagement of a GPCR with the α5-helix and αN-β1 loop leads to concerted changes in the α1 helix and P loop that destabilize contacts with the guanine nucleotide, leading to its release 27 .
Structural insights into G i -coupling specificity of the µOR
Although the µOR couples exclusively to G i/o 3 , many GPCRs can couple to multiple G-protein subtypes. A well-studied example is the β 2 AR, which couples to both G s and G i/o . Previous sequence-level analyses have failed to identify a linear GPCR epitope that determines G-protein-coupling specificity, suggesting that specificity is likely to be determined by a more complex three-dimensional network of interactions. Globally, the structure of the µOR-G i complex is similar to that of the β 2 AR-G s complex; this is likely to reflect a similarity in the conformation of nucleotide-free states of family A GPCR-G-protein complexes. The primary interaction sites in Article reSeArcH both complexes occur between ICL2, ICL3 and TM3, TM5 and TM6 on the receptor and the αN, αN-β1 loop and α5-helix on the Gα subunit of the G protein ( Fig. 4) . The most striking differences between the β 2 AR-G s and µOR-G i complexes are in the relative position of the α5-helix of both G proteins and the corresponding shift in the position of TM6 in the receptor. The α5-helix of Gα i is rotated ~21° relative to the α5-helix of Gα s , leading to a 5 Å displacement of the extreme C terminus of the Gα i helix α5 toward TM7 of the µOR (Fig. 4a ). This difference in α5 positioning is associated with a smaller outward displacement of the µOR TM6. The C-terminal residues of α5 that interact with TM5 and TM6 of the receptor are bulkier in G s than in G i , with tyrosine and glutamate in place of cysteine and glycine at positions −4 and −3 from the C terminus, respectively. Accordingly, substitution of these two amino acids of G s into G i would lead to steric clashes with TM3 and the TM7-helix 8 loop (Extended Data Fig. 7 ). In the G s -coupled family B calcitonin 11 and GLP-1 10 receptors, G-protein coupling is associated with a large kink of TM6 at the conserved PXXG motif, which produces an even larger outward displacement of TM6 than that observed in the β 2 AR-G s complex.
Surprisingly, the structure of µOR-G i shows substantial similarity to an active-state structure of the visual pigment rhodopsin (metarhodopsin II) in complex with a modified peptide derived from the 11 C-terminal residues of the α-subunit of the visual G protein transducin (Gα t CT2) 28 (Extended Data Fig. 8 ). Despite the absence of the rest of the heterotrimeric G protein in the metarhodopsin II-Gα t CT2 structure, the conformation of TM6 of metarhodopsin II is highly similar to that of the µOR, and the location of the Gα t CT2 peptide is almost identical to that of the C terminus of G i in complex with µOR. This finding is consistent with observations showing that substitution of the last five amino acids of the α5-helix of Gα is sufficient to change G-protein-coupling specificity 29 .
In Extended Data Table 2 , we list amino acids in the µOR that interact with the cytoplasmic surface of G i . The ICL2 of µOR primarily forms interactions with the αN and α5 helices of Gα i , including a key ionic interaction between D177 34.55 of µOR (G Protein Coupled Receptor Data Base (GPCRDB) numbering 30 ) in ICL2 and R32 in the αN-β1 loop of Gα i (Fig. 4b ). Although D 34.55 in ICL2 is conserved in all opioid receptors with available sequences (GPCRDB 31 ), it is variable in most other G i -coupled receptors. Another notable interaction involves R179 34.57 in ICL2 of µOR, which simultaneously coordinates the highly conserved D164 3.49 in the D 3.49 R 3.50 Y 3.51 motif and potentially forms an additional interaction with D350 (−5 position) in the α5-helix of Gα i (Fig. 4b ). This arginine residue is essential for µOR-induced G i signalling, as the polymorphic variant R179C abolishes signalling in vitro 32 and leads to insensitivity to morphine in patients homozygous for the mutation 33 . The potential role of this interaction network in G-protein coupling is supported by the preponderance of basic residues (arginine and lysine) at this position in most G i -coupled receptors, whereas G scoupled receptors contain alternative residues at the equivalent position (Extended Data Table 2 ).
A further group of contacts occurs between P172 34.50 and V173 34.51 of µOR and a hydrophobic patch on Gα i comprised of residues F336, I343, I344 and T340 on the α5-helix and L194 on the β2-β3 loop (Fig. 4b, d ).
In the GDP bound state, these α5-helix residues are buried by the adjacent β2 and β3 loops. Coupling to a receptor involves an upward shift of the α5-helix and exposes these residues to form a shallow hydrophobic pocket that interacts with µOR V173 34.51 in ICL2 ( Fig. 4b, d ). In the case of G s , a deeper hydrophobic pocket in this region engages the bulky aromatic F139 34.51 in ICL2 of the β 2 AR (Fig. 4c, d) .
In the µOR, ICL3 stabilizes the interface between receptor and G protein through two sets of interactions: one set involves multiple contacts with a hydrophobic patch on the α5-helix of Gα i , while another engages the β6 strand of Gα i through a network of charged residues (Fig. 5a , c). The hydrophobic interface formed by ICL3 is similar in both the µOR and β 2 AR; in the β 2 AR, TM5 is helically extended to form a larger hydrophobic interaction around nonpolar residues in the α5-helix of Gα s (Fig. 5b) . The shorter ICL3 of the µOR does not form a similar helical extension, but it nevertheless fulfills the same role. Residues V262 5.68 , M264 and L265 fold back to form a hydrophobic patch that interacts with hydrophobic residues on the α5-helix of Gα i (Fig. 5a ). 
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The second set of polar contacts involves R263 of µOR and the backbone carbonyl of I319 on the β6 strand of Gα i (Fig. 5a ). Mutations of R263 reduce, but do not abolish, G i signalling 34 , which is consistent with the potential importance of stabilizing the β6 strand of Gα i in the observed conformation. There is no analogous interaction in the β 2 AR-G s complex (Fig. 5b) . This additional recognition interface may be necessary for efficient µOR-G i coupling owing to the higher affinity for GDP of G i relative to G s . Compared to G s -coupled receptors, additional interactions with the β6 strand in G i -coupled receptors may be required to disrupt interactions between the Ras domain and GDP for efficient nucleotide exchange.
The cytosolic ends of µOR TM3, TM5 and TM6 further stabilize the nucleotide-free conformation of the α5-helix by interacting with highly conserved residues in the distal C terminus of Gα i (Fig. 5c ). In particular, C351 (−4 position) of Gα i is in close proximity to the cytosolic end of TM3 of µOR. This cysteine residue has previously been identified as the site of pertussis toxin-mediated inhibition of G i/o family proteins by enzymatic ADP ribosylation 35 . The close apposition of C351 to the cytoplasmic surface of µOR highlights how the addition of a bulky modification at this position can completely inhibit receptor coupling and nucleotide exchange 35 . In addition to this interaction, µOR residues M255 5.61 , I278 6.33 , M281 6.36 and V282 6.37 form a hydrophobic pocket that engages the absolutely conserved Gα i residue L353 (−2 position) in the α5-helix. M255 5.61 and M281 6.36 have previously been observed in NMR experiments to respond to activation by DAMGO 36 , suggesting that this region undergoes conformational changes prior to G-protein coupling. Further stabilization, however, is likely to be provided by a hydrogen bond between R277 6.32 and the backbone carbonyl of L353 (Fig. 5b) . Notably, interactions between the C terminus of the α5-helix and the receptor core are entirely different in the β 2 AR-G s complex (Fig. 5d ).
Our findings provide structural insights into why µOR does not couple to G s , but do not explain the mechanism of G-proteincoupling specificity across all GPCRs. It is possible that coupling specificity is determined at an intermediate step in the formation of a GPCR-G-protein complex, such as the initial interactions between the GDP-bound G protein and the agonist-bound receptor. Recent single molecule fluorescence studies provide evidence for a transient intermediate complex between GDP-bound G s and the β 2 AR that is associated with a smaller outward movement of TM6 37 . Previous studies suggest that amino acids C-terminal to helix 8 confer coupling specificity for G q in the M 3 muscarinic receptor (M 3 R) 38 . Given that there are no interactions between the C termini of the β 2 AR or µOR and their respective G proteins in the nucleotide-free complexes, we hypothesize that engagement of G q with the C terminus of M 3 R may occur at an earlier stage in complex formation. Thus, the nucleotide-free GPCR-Gprotein complex may be preceded by one or more GDP-bound intermediates characterized by dynamic low-affinity interactions with the receptor. Such 'initial encounter' complexes may show larger energetic differences among interactions with various G-protein subtypes than the nucleotide-free state, and would thereby contribute more critically to coupling specificity. The transient nature of such interactions, however, poses challenges for structure determination by crystallography or cryo-EM.
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MEthodS
No statistical methods were used to predetermine sample size. The experiments were not randomized and the investigators were not blinded to allocation during experiments and outcome assessment. Purification of µOR. These studies utilized a previously described mouse µOR construct with cleavable N-and C-terminal domains 12 . In brief, the receptor was expressed in Spodoptera frugiperda Sf9 insect cells using the baculovirus method (Expression Systems), extracted from insect cell membranes with n-dodecyl-β-d-maltoside (DDM, Anatrace), and purified by nickel-chelating sepharose chromatography. The Ni-NTA eluate was loaded onto M1 anti-Flag immunoaffinity resin and washed with progressively lower concentrations of the antagonist naloxone. The µOR was then eluted in a buffer consisting of 20 mM Hepes pH 7.5, 100 mM NaCl, 0.1% DDM and 0.01% cholesterol hemisuccinate (CHS) supplemented with 50 nM naloxone, Flag peptide and 5 mM EDTA. The monomeric fraction was purified by size exclusion chromatography on a Superdex 200 10/300 gel filtration column (GE Healthcare) in 20 mM Hepes pH 7.5, 100 mM NaCl, 0.1% DDM, 0.01% CHS, and 1 µM DAMGO. A further twofold molar excess of DAMGO was added to the preparation and the resulting agonist-bound µOR preparation was concentrated to ~100 µM. Expression and purification of heterotrimeric G i . Heterotrimeric G i was expressed and purified as previously described 24 . In brief, Trichuplusia ni Hi5 insect cells were co-infected with two viruses, one encoding the wild-type human Gα i subunit and another encoding the wild-type human β 1 γ 2 subunits with an octahistidine tag inserted at the amino terminus of the β 1 subunit. Cultures were harvested 48 h post infection. Cells were lysed in hypotonic buffer and lipid-modified heterotrimeric G i was extracted in a buffer containing 1% sodium cholate. The soluble fraction was purified using Ni-NTA chromatography, and the detergent was exchanged from cholate to DDM on a column. After elution, the protein was dialyzed against a buffer containing 20 mM Hepes pH 7.5, 100 mM NaCl, 0.015% DDM, 100 µM TCEP, 10 µM GDP, and concentrated to ~20 mg/ml for further complexing with the µOR. Generation of scFv16. Six to eight week old female Balb/c mice were immunized with a purified rhodopsin-G i complex 39 . Hybridoma cells were prepared using splenocytes of immunized mice using standard methods in combination with PAI myeloma cells (RRID: CVCL J288). Clones that showed a positive reaction to purified rhodopsin(N2C/D282C/M257Y)-G i1 complex in an ELISA assay and by immunoprecipitation were further characterized as monoclonal antibodies or Fab fragments. Fab-16 was selected from the initial pool of clones because it prevented dissociation of the rhodopsin(N2C/D282C/M257Y)-G i1 complex by GTPγS, and therefore acted as a stabilizing chaperone in the same manner as Nb35 for G s . The full sequences of constructs used are listed in Supplementary Fig. 1 . All animal studies were performed at Roche Innovation Center in Basel according to ethical guidelines and internal IRB approval. All cell lines were obtained from the manufacturer and tested for contamination.
A C-terminal hexahistidine-tagged single chain construct of Fab16 (scFv16) was cloned into a modified pVL1392 vector containing a GP67 secretion signal immediately prior to the amino terminus of the scFv, expressed in secreted form from Trichuplusia ni Hi5 insect cells using the baculovirus method, and purified by Ni-NTA chromatography. Supernatant from baculovirus-infected cells was pH balanced by addition of Tris pH 8.0. Chelating agents were quenched by addition of 1 mM nickel chloride and 5 mM calcium chloride and incubation with stirring for 1 h at 25 °C. Resulting precipitates were removed by centrifugation and the supernatant was loaded onto Ni-NTA resin. The column was washed with 20 mM Hepes pH 7.5, 500 mM NaCl, and 10 mM imidazole followed by a low salt wash comprised of the same buffer substituted with 100 mM NaCl. Following elution with the same buffer supplemented with 250 mM imidazole, the C-terminal hexahistidine tag was cleaved by incubation with human rhinovirus 3C protease, and the protein was dialyzed into a buffer consisting of 20 mM Hepes pH 7.5 and 100 mM NaCl. Cleaved scFv16 was further purified by reloading over Ni-NTA resin. The flowthrough was collected and purified over gel filtration chromatography using a Superdex 200 16/60 column. Monomeric fractions were pooled, concentrated, and flash frozen in liquid nitrogen until further use. Formation and purification of the µOR-G i -scFv16 complex. Purified DAMGObound µOR was mixed with a 1.2 molar excess of G i heterotrimer. The coupling reaction was allowed to proceed at 24 °C for 1 h and was followed by addition of apyrase to catalyze hydrolysis of unbound GDP, which destabilizes the nucleotidefree complex 40 . After one more hour at 25 °C, a fourfold volume of 20 mM Hepes pH 7.5, 100 mM NaCl, 1% lauryl maltose neopentyl glycol (L-MNG), 0.1% CHS was added to the complexing reaction to initiate detergent exchange. After 1 h incubation at 25 ºC to allow micelle exchange, 1 mM MnCl 2 and lambda phosphatase (New England Biolabs) were added to dephosphorylate the preparation. This reaction was further incubated at 4 °C for 2 h. To remove excess G protein and residual DDM, the complexing mixture was purified by M1 anti-Flag affinity chromatography. Bound complex was first washed in a buffer containing 1% L-MNG, followed by washes in gradually decreasing L-MNG concentrations. The complex was then eluted in 20 mM Hepes pH 7.5, 100 mM NaCl, 0.01% L-MNG, 0.001% CHS, 300 nM DAMGO, 5 mM EDTA and Flag peptide. The eluted complex was supplemented with 100 µM TCEP to provide a reducing environment. The tobacco etch virus (TEV) protease and human rhinovirus 3C protease were added to cleave the flexible µOR N and C termini. Finally, a 1.2 molar excess of scFv16 was added to the preparation. Once cleavage of the termini was confirmed by SDS-PAGE, the µOR-G i -scFv16 complex was purified by size exclusion chromatography on a Superdex 200 10/300 column in 20 mM Hepes pH 7.5, 100 mM NaCl, 300 nM DAMGO, 0.00075% L-MNG and 000025% glyco-diosgenin (GDN) with 0.0001% CHS total. Peak fractions were concentrated to ~7 mg/ml for electron microscopy studies. Cryo-EM and 3D reconstructions of µOR-G i -scFv16 complex. Three microlitres of purified µOR-G i -scFv16 complex was applied to glow-discharged 200-mesh grids (Quantifoil R1.2/1.3) and subsequently vitrified using a Vitrobot Mark IV (Thermo Fischer Scientific). Cryo-EM imaging was performed on a Titan Krios operated at 300 kV at a nominal magnification of 130,000× using a Gatan K2 Summit direct electron camera in counted mode, corresponding to a pixel size of 1.04 Å. A total of 2642 image stacks were obtained with a defocus range of −0.8 to −2.6 µm. Each stack movie was recorded for a total of 8 s with 0.1 s per frame. The dose rate was 5 e − /Å 2 /s, resulting in an accumulated dose of 40 electrons per Å 2 .
Dose-fractionated image stacks were subjected to beam-induced motion correction using MotionCor2 41 . A sum of all frames, filtered according to exposure dose, in each image stack was used for further processing. CTF parameters for each micrograph were determined by Gctf v1.06 42 . Particle selection, two-dimensional and three-dimensional classification, and 3D reconstruction were performed using RELION2.1 43 , apart from the last round of local refinement and reconstruction that was performed with Frealign 44 . Semi-automated selected 893,426 particle projections were subjected to reference-free 2D classification and averaging using a binned dataset with a pixel size of 2.08 Å. Particles (379,373) with well-defined averages were subjected to further processing. An ab initio map generated by VIPER 45 was used as initial reference model for maximum-likelihood-based 3D classification, which, however, did not produce classes with notable differences. Thus, all 379,373 particle projections were subjected to 3D refinement, producing a map at 4.3 Å resolution. The dataset was further reduced by removing particle projections from micrographs with resolution lower than 4.5 Å, resulting in a dataset of 359,406 particles that were subjected to refinement and reconstruction after subtracting densities for the mobile Gα α-helical domain and the detergent micelle 11 . Particle projection assignments from RELION were imported into Frealign 46 for a final round of local refinement and reconstruction. To prevent overfitting, the resolution limit for each alignment iteration never exceeded the 0.9 value of the Frealign calculated Fourier shell correlation (FSC). The map was further improved after additionally subtracting densities corresponding to the ScFv from the raw particle projections 11 . The indicated resolution, using Phenix 'gold standard' FSC 47 , of the final reconstruction is 3.5 Å and 3.6 Å at FSC 0.143 for the ScFv-subtracted map and the ScFv-including map, respectively. Local resolution was determined using the Bsoft package 48 with unfiltered half maps as input. Model building and refinement. The building of a full atomic model for the µOR-G i complex was aided by the quality and resolution of our map, as well as the existence of high-resolution crystal structures of each of the components that make up the complex. A composite model was formed by rigid body fitting of the active-state µOR (PDB code 5C1M) 12 with nanobody removed, as well as the Ras domain and βγ subunits of GDP-bound G i (PDB 1GP2) 23 . The α5-helix of Gα i was removed and manually fitted to the density, and the final eight residues that were missing from the extreme C terminus of the 1GP2 structure were manually built in Coot 49 . This starting model was then subjected to iterative rounds of automated refinement in Rosetta 50 and Phenix real space refine 47 , and manual building in Coot 49 . In the regions of the model for which side-chain density was too weak to unambiguously assign a conformation, we stubbed residues to their C β position, while preserving sequence information ( Supplementary Fig. 2, 3 ). The final model was visually inspected for general fit to the map, and geometry was further evaluated using Molprobity 51 as part of the Phenix suite of software. Initial restraints for DAMGO were generated using the PRODRG server 52 . To further refine the pose of DAMGO, we chose a pose from molecular dynamics simulation consistent with our map and then performed a refinement using Phenix. This involved manually editing the residue and atom names from a CHARMM parameter file to match the three-letter codes and atom names from the RCSB. In particular, DAL for d-alanine, MEA for N-methyl phenylalanine, and ETA for Gly-ol C terminus. Additional, custom, restraints were generated to maintain planarity of the final peptide bond between MEA and ETA as a supplement to the natural library of Phenix amino acid restraints. Model overfitting was evaluated through its refinement against one cryo-EM half map after randomly displacing all atoms by 0.2 Å. FSC curves were calculated between the resulting model and the half map used for refinement ( red curve, Extended Data Fig. 3b, c) , as well as between the resulting Article reSeArcH model and the other half map for cross validation (green curve, Extended Data Fig. 3b, c) , and also against the full map ( black curve, Extended Data Fig. 3b, c) . The final refinement statistics for both models are provided in Extended Data Table 1 . System setup for molecular dynamics simulations. Molecular dynamics simulations were initiated from an earlier refinement of the structure reported in this study after removing the G protein and ScFv fragment. Prior to beginning simulations, Schrödinger Glide 53 was used to relax DAMGO to an energetically favourable conformation. The initial DAMGO pose is depicted in Extended Data Fig. 3 . We performed five independent simulations, for each of which initial atom velocities were assigned randomly and independently. Prime (Schrödinger) was used to model missing side chains, and neutral acetyl and methylamide groups were added to cap protein termini. Titratable residues remained in their dominant protonation state at pH 7, as determined using PropKa, except for D 2.50 and D 3.49 , which were protonated. Our simulations incorporated the waters from the 5C1M crystal structure.
The prepared protein structures were aligned to the 'orientation of proteins in membranes' (OPM) structure for PDB entry 5C1M 54 . The aligned structures were then inserted into a pre-equilibrated palmitoyl-oleoyl-phosphatidylcholine (POPC) bilayer using Dabble, a simulation preparation software 55 . Sodium and chloride ions were added to neutralize each system at a concentration of approximately 150 mM. Bilayer dimensions were chosen to maintain at least a 30 Å buffer between protein images in the x-y plane and a 20 Å buffer between protein images in the z direction. Final system dimensions were approximately 80 × 75 × 90 Å 3 . Simulation times for each replicate were approximately 1 µs. Molecular dynamics simulation protocols. We used the CHARMM36m force field for proteins, lipids and ions and the TIP3P model for waters [56] [57] [58] [59] [60] . Parameters for the non-canonical residues in DAMGO were determined by analogy to N-methyl glycine for assigning N-methyl parameters to N-methyl phenylalanine (residue 4) and by analogy to serine to assign parameters to the Gly-ol capping group (residue 5). CMAP terms for d-alanine were inverted from those for l-Alanine to account for the inverted chirality of the residue.
We performed the simulations using the Compute Unified Device Architecture (CUDA) version of Particle-Mesh Ewald Molecular Dynamics (PMEMD) in AMBER on one or two graphical processing units (GPUs) 61 . Simulations were performed using the AMBER16 62 software. Three rounds of minimization were performed, each consisting of 500 iterations of steepest descent minimization, followed by 500 iterations of conjugate gradient descent minimization, with harmonic restraints of 10.0, 5.0 and 1.0 kcal mol −1 Å −2 placed on the protein and lipids. Systems were heated from 0 K to 100 K in the NVT ensemble over 12.5 ps and then from 100 K to 310 K in the NPT ensemble over 125 ps, using 10.0 kcal mol −1 Å −2 harmonic restraints applied to lipid and protein heavy atoms. Systems were then equilibrated at 310 K in the NPT ensemble at 1 bar, with harmonic restraints on all protein heavy atoms tapered off by 1.0 kcal mol −1 Å −2 starting at 5.0 kcal mol −1 Å −2 in a stepwise fashion every 2 ns for 10 ns and then by 0.1 kcal mol −1 Å −2 in a stepwise fashion every 2 ns for 20 ns. Production simulations were performed in the NPT ensemble at 310 K and 1 bar, using a Langevin thermostat for temperature coupling and a Monte Carlo barostat for pressure coupling. These simulations used a 4-fs time step with hydrogen mass repartitioning 63 . Bond lengths to hydrogen atoms were constrained using SHAKE. Simulations used periodic boundary conditions. Non-bonded interactions were cut off at 9.0 Å, and long-range electrostatic interactions were computed using Particle Mesh Ewald (PME) with an Ewald coefficient of approximately 0.31 Å and an interpolation order of four. The FFT grid size was chosen such that the width of a grid cell was approximately 1 Å.
During production simulations, all residues within 5 Å of the G-protein interface were restrained to the initial structure using 5.0 kcal mol −1 Å −2 harmonic restraints applied to non-hydrogen atoms. Using such restraints reduces the overall system size, enabling more simulation, while ensuring that the receptor maintains an active conformation throughout the simulation. Analysis protocols for molecular dynamics simulation. Trajectory snapshots were saved every 200 ps during production simulations. The AmberTools17 CPPTRAJ package was used to reimage and center trajectories 64 . Simulations were visualized and analysed using Visual Molecular Dynamics (VMD) 65 . In two simulations, DAMGO was trapped in an unstable binding pose, wherein the water-mediated interaction between the DAMGO tyrosine residue and H297 failed to form during equilibration, and instead a direct hydrogen bond between these residues was formed. Our analysis is based on the other three simulations, in which DAMGO's pose was consistent with the cryo-EM density. Water occupancy maps were generated using AmberTools17 GIST 66, 67 . Frames from every 1 ns of simulation, excluding the first 400 ns, aligned to the initial structure, were used as input. The grid size was set to 0.25 Å. The resulting map was smoothed using a Gaussian filter with a standard deviation of two grid cells. A description of all covariates tested A description of any assumptions or corrections, such as tests of normality and adjustment for multiple comparisons A full description of the statistics including central tendency (e.g. means) or other basic estimates (e.g. regression coefficient) AND variation (e.g. standard deviation) or associated estimates of uncertainty (e.g. confidence intervals)
For null hypothesis testing, the test statistic (e.g. F, t, r) with confidence intervals, effect sizes, degrees of freedom and P value noted Our web collection on statistics for biologists may be useful.
Software and code
Policy information about availability of computer code
Data collection
Automated data collection on the Titan Krios was performed using serialEM
Data analysis
The following software was used in this study: MotionCor2, gCTF v1.06, RELION 2.1, FREALIGN, cisTEM, BSoft, UCSF Chimera, UCSF ChimeraX, Coot, Pymol, Phenix, Rosetta, PRODRG Server, AMBER17, VIPER For manuscripts utilizing custom algorithms or software that are central to the research but not yet described in published literature, software must be made available to editors/reviewers upon request. We strongly encourage code deposition in a community repository (e.g. GitHub). See the Nature Research guidelines for submitting code & software for further information.
Data
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-Accession codes, unique identifiers, or web links for publicly available datasets -A list of figures that have associated raw data -A description of any restrictions on data availability All data generated or analyzed during this study are included in this published article and its Supplementary Information. Sequences of constructs used in this study 2 nature research | reporting summary
March 2018
are listed in Supplementary Figure 1 . The cryo-EM density maps for the mOR-Gi complex with, and without scFv16 have been deposited in the Electron Microscopy Data Bank under accession codes EMD-XXXX and EMD-YYYY respectively. The coordinates for the models of mOR-Gi with, and without scFv16 have been deposited in the Protein Data Bank under accession codes XXXX and YYYY, respectively.
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Study design
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Sample size
Sample size was not pre-determined by any statistical metrics. Sample size was limited by time allocation on microscopes, subsequent processing of images confirmed we had enough data to reach high resolution.
Data exclusions No data was systematically excluded. Over the course of refinement of our maps, particles with low signal, or particles that did not align well to the consensus map were excluded from final map calculations as implemented in RELION 2.1 and FREALIGN.
Replication
No replication studies were attempted, nor were necessary. Our primary data is a cryo-EM structure that was calculated according to standard procedures and does not need replicates.
Randomization No randomization was necessary for this study. Our primary data is a calculated cryo-EM structure that was calculated according to standard procedures with freely available software and does not need randomization.
Blinding
No blinding was used or necessary during data collection or analysis. As above, Our primary data is a calculated cryo-EM structure that was calculated according to standard procedures with freely available software and did not require blinding. We calculated our initial model abinitio to avoid bringing model bias into our map calculation, and in a sense, blinded the software.
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Unique materials
Obtaining unique materials scFv16 is the property of F. Hoffmann-La Roche Ltd (Roche) and is available upon request by MTA.
Antibodies
Antibodies used scFv16 came from an antibody (mAb-16) that binds the Gi heterotrimer. This antibody was generated by Roger Dawson at F Hoffmann-La Roche Ltd (Roche). As above, it is available upon request by MTA.
Validation
Binding was confirmed by size-exclusion chromatography on purified protein, as well as by ELISA. Sequencing was performed on mouse hybridoma cells producing mAb16 and the scFv fragment was cloned. Binding of this scFv fragment was confirmed by size exclusion chromatography and electron microscopy. This antibody was generated for the purposes of this study. Most of the scFv could be built into density and register was confirmed.
Eukaryotic cell lines
Policy information about cell lines Cell line source(s) Sf9, Expression Systems, Cat 94-001S. Tni Cells (Hi-5), Expression Systems, Cat 94011S. PAI mouse myeloma cell lines (a variant of the P3-x63-AG8 myeloma) as : PAI (RRID:CVCL_J288). The myeloma cells were obtained from the Basel Institute of Immunology.
